Evidence map›Paper›PMID 25764512›Full record

ArticlePLoS pathogens2015

Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection.

Darin L Wiesner, Charles A Specht, Chrono K Lee, Kyle D Smith, Liliane Mukaremera, S Thera Lee, Chun G Lee, Jack A Elias, Judith N Nielsen, David R Boulware and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 216 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Immunomodulation in the Treatment of Disseminated Coccidioidomycosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Type-2 immune skewing in patients with disseminated coccidioidomycosis.medRxiv : the preprint server for health sciences · 2025
    Article
  14. Article
  15. Review
  16. Insights from Mass Spectrometry-Based Proteomics onJournal of fungi (Basel, Switzerland) · 2025
    Review
  17. Review
  18. Article
  19. The hypervirulent Type-1/Type-17 phenotype ofInfection and immunity · 2025
    Article
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Darin L WiesnerDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
Charles A SpechtDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Chrono K LeeDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Kyle D SmithDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
Liliane MukaremeraDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
S Thera LeeDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
Chun G LeeSection of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Jack A EliasWarren Alpert Medical School, Division of Biology and Medicine, Brown University, Providence, Rhode Island.
Judith N NielsenDepartment of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina.
David R BoulwareDivision of Infectious Diseases and International Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota.
Paul R BohjanenDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota; Division of Infectious Diseases and International Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota.
Marc K JenkinsDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
Stuart M LevitzDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Kirsten NielsenDepartment of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota.
University of Minnesota Medical Center · USUniversity of Massachusetts Chan Medical School · USBrown University · USUniversity of North Carolina at Chapel Hill · USYale University · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
TRACKING CD4+ MEMORY T CELLS IN VIVOR01AI039614 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JENKINS, MARC KEVIN · 1996 to 2023
$8.7M
ROLE OF MACROPHAGES IN CRYPTOCOCCAL INFECTIONSR01AI025780 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL · 1987 to 2019
$7.1M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Chitosan in CryptococcusR01AI072195 · NIAID · WASHINGTON UNIVERSITY · PI LODGE, JENNIFER K. · 2008 to 2018
$3.5M
Pheromones and Titan Cell Production in Cryptococcus neoformansR01AI080275 · NIAID · UNIVERSITY OF MINNESOTA · PI NIELSEN, KIRSTEN · 2011 to 2015
$1.8M
Interactions of pDCs with AspergilusR01HL112671 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL · 2013 to 2016
$1.7M
Outcomes of Cryptococcal Meningitis in UgandaK24AI096925 · NIAID · UNIVERSITY OF MINNESOTA · PI BOHJANEN, PAUL R · 2011 to 2015
$1.0M
Immunostimulatory properties of chitin and chitosanR21AI093302 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL, SPECHT, CHARLES A · 2011 to 2012
$452k
NCATS NIH HHS UL1 TR000114NCI NIH HHS P30 CA077598NHLBI NIH HHS HL112671NHLBI NIH HHS R01 HL112671NIAID NIH HHS AI025780NIAID NIH HHS AI039614NIAID NIH HHS AI072195NIAID NIH HHS AI080275NIAID NIH HHS AI089067NIAID NIH HHS AI093302NIAID NIH HHS K24 AI096925NIAID NIH HHS R01 AI025780NIAID NIH HHS R01 AI039614NIAID NIH HHS R01 AI072195NIAID NIH HHS R01 AI080275NIAID NIH HHS R21 AI093302NIAID NIH HHS T32 AI007313
6 · The paper itself

Abstract

Pulmonary mycoses are often associated with type-2 helper T (Th2) cell responses. However, mechanisms of Th2 cell accumulation are multifactorial and incompletely known. To investigate Th2 cell responses to pulmonary fungal infection, we developed a peptide-MHCII tetramer to track antigen-specific CD4+ T cells produced in response to infection with the fungal pathogen Cryptococcus neoformans. We noted massive accruement of pathologic cryptococcal antigen-specific Th2 cells in the lungs following infection that was coordinated by lung-resident CD11b+ IRF4-dependent conventional dendritic cells. Other researchers have demonstrated that this dendritic cell subset is also capable of priming protective Th17 cell responses to another pulmonary fungal infection, Aspergillus fumigatus. Thus, higher order detection of specific features of fungal infection by these dendritic cells must direct Th2 cell lineage commitment. Since chitin-containing parasites commonly elicit Th2 responses, we hypothesized that recognition of fungal chitin is an important determinant of Th2 cell-mediated mycosis. Using C. neoformans mutants or purified chitin, we found that chitin abundance impacted Th2 cell accumulation and disease. Importantly, we determined Th2 cell induction depended on cleavage of chitin via the mammalian chitinase, chitotriosidase, an enzyme that was also prevalent in humans experiencing overt cryptococcosis. The data presented herein offers a new perspective on fungal disease susceptibility, whereby chitin recognition via chitotriosidase leads to the initiation of harmful Th2 cell differentiation by CD11b+ conventional dendritic cells in response to pulmonary fungal infection.

Indexed as

AnimalsAntigens, FungalChitinCryptococcosisCryptococcus neoformansDendritic CellsDisease Models, AnimalFlow CytometryHexosaminidasesLung Diseases, FungalLymphocyte ActivationMiceMice, Inbred C57BLMicroscopy, FluorescenceTh2 CellsAntigens, FungalChitinchitotriosidaseHexosaminidases

Identifiers

PMID25764512
PMCPMC4357429
OpenAlexW2005361432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.